On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson’s Psychosis

Parkinson’s disease psychosis (PDP) is a condition that may develop in up to 60 % of Parkinson’s patients, and is a major reason for nursing home placement for those affected. There are no FDA approved drugs for PDP but low doses of atypical anti-psychotic drugs (APDs) are commonly prescribed off-la...

Descripción completa

Detalles Bibliográficos
Autores principales: Hacksell, Uli, Burstein, Ethan S., McFarland, Krista, Mills, Roger G., Williams, Hilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Overview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172996/
https://www.ncbi.nlm.nih.gov/pubmed/24682754
http://dx.doi.org/10.1007/s11064-014-1293-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172996/
https://www.ncbi.nlm.nih.gov/pubmed/24682754
http://dx.doi.org/10.1007/s11064-014-1293-3

Ejemplares similares